The Freud Reader Quiz | Eight Week Quiz C

This set of Lesson Plans consists of approximately 124 pages of tests, essay questions, lessons, and other teaching materials.
Related Topics

The Freud Reader Quiz | Eight Week Quiz C

This set of Lesson Plans consists of approximately 124 pages of tests, essay questions, lessons, and other teaching materials.
Buy The Freud Reader Lesson Plans
Name: _________________________ Period: ___________________

This quiz consists of 5 multiple choice and 5 short answer questions through Chapter 6, The Theory of Sexuality Continued.

Multiple Choice Questions

1. Which of the following is NOT a characteristic for what Freud terms the 'anal character'?
(a) Orderly.
(b) Parsimonious.
(c) Organized.
(d) Obstinate.

2. What drug does Freud research?
(a) Cocaine.
(b) LSD.
(c) Marijuana.
(d) Extasy.

3. According to the editor, from what does the current American society suffer?
(a) Lack of perception into what they feel.
(b) Homosexuality.
(c) Anxiety related to recognizing and treating neuroses and hysteria.
(d) Obesity.

4. What did Freud's mentor decipher?
(a) The reasons people are neurotic.
(b) How to diagnose a severe case of multiple personalities.
(c) Hysterical and neurotic symptoms in men and women.
(d) Dora's illness.

5. Who is the first official patient of psychotherapy?
(a) Anna O.
(b) Charcot.
(c) Dora.
(d) John Kerry.

Short Answer Questions

1. What happens to the patient that makes her sick in "The Making of Psychoanalysis"?

2. According to Freud, what type of discernible relationship is typically found in what he calls the 'anal character'?

3. What does Freud refer to as an 'incurable ailment'?

4. What does Freud say about children that are twelve years old in "The Theory of Sexuality"?

5. How many different sections are used in Chapter 6, "The Theory of Sexuality"?

(see the answer key)

This section contains 253 words
(approx. 1 page at 300 words per page)
Buy The Freud Reader Lesson Plans
Copyrights
BookRags
The Freud Reader from BookRags. (c)2024 BookRags, Inc. All rights reserved.